Sartorius Stedim Biotech S.A. (SDMHF)
OTCMKTS · Delayed Price · Currency is USD
205.68
0.00 (0.00%)
Aug 21, 2025, 4:00 PM EDT
Sartorius Stedim Biotech Market Cap
Sartorius Stedim Biotech has a market cap or net worth of $20.29 billion as of August 22, 2025. Its market cap has increased by 11.39% in one year.
Market Cap
20.29B
Enterprise Value
22.99B
Revenue
3.40B
Ranking
n/a
PE Ratio
76.73
Stock Price
$205.68
Market Cap Chart
Since March 13, 2008, Sartorius Stedim Biotech's market cap has increased from 737.16M to 20.29B, an increase of 2,653.03%. That is a compound annual growth rate of 20.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 20.29B | 6.75% |
| Dec 31, 2024 | 19.01B | -22.08% |
| Dec 29, 2023 | 24.40B | -18.13% |
| Dec 30, 2022 | 29.80B | -41.07% |
| Dec 31, 2021 | 50.57B | 54.01% |
| Dec 31, 2020 | 32.84B | 114.91% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 610.45M |
| Glass House Brands | 554.44M |
| Nika Pharmaceuticals | 453.04M |
| American Oncology Network | 398.51M |
| CytoDyn | 365.94M |
| Northwest Biotherapeutics | 355.76M |